EVERSANA, a leading provider of global commercial services to the life sciences industry, has announced two strategic ...

Alpha-1 is a microcosm of the rare disease world. The challenges we face, late diagnoses, inconsistent care, and unaffordable ...

The announcement builds on AZ's announcement earlier this year that it will invest $2.5 billion in an R&D facility in China, ...

Describing the current treatment landscape for primary and secondary bone cancer, Romness explains the potential of their own ...

US Senators Bernie Sanders and Angus King have introduced a bill that seeks to ban direct-to-consumer (DTC) advertising by ...

A fourth revolution in cancer care is taking shape, one that steps away from the current well-trodden path. This revolution ...

The Health and Human Services (HHS) Secretary named eight hand-picked members of the Advisory Committee on Immunisation ...

Full results from the first phase 3 trial of UCB and Biogen's anti-CD40L antibody dapirolizumab pegol (DZP) in systemic lupus ...

England is the first country in the world to make GSK's anti-BCMA drug Blenrep available to patients with the haematological ...